Evidence map›Paper›PMID 37464464›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Pumped and pumpless microphysiological systems to study (nano)therapeutics.

Eun-Jin Lee, Zachary L Krassin, Hasan Erbil Abaci, Gretchen J Mahler, Mandy B Esch

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eun-Jin LeeDepartment of Chemistry and Biochemistry, College of Computer, Mathematical and Natural Sciences, University of Maryland, College Park, Maryland, USA.ORCID 0000-0001-5718-542X
Zachary L KrassinDepartment of Biomedical Engineering, Binghamton University, Binghamton, New York, USA.ORCID 0000-0002-1651-5522
Hasan Erbil AbaciDepartment of Dermatology, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0002-4735-7790
Gretchen J MahlerDepartment of Biomedical Engineering, Binghamton University, Binghamton, New York, USA.ORCID 0000-0002-7286-8920
Mandy B EschMicrosystems and Nanotechnology Division, Physical Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.ORCID 0000-0001-6868-1867

Funding

Engineering a Small Intestinal Microbiome to Evaluate Food Additive ExposureR01ES028788 · NIEHS · STATE UNIVERSITY OF NY,BINGHAMTON · PI MAHLER, GRETCHEN, MARQUES, CLAUDIA N.H. · 2018 to 2022
$1.5M
Intramural NIST DOC 9999-NISTNIEHS NIH HHS R01 ES028788
6 · The paper itself

Abstract

Fluidic microphysiological systems (MPS) are microfluidic cell culture devices that are designed to mimic the biochemical and biophysical in vivo microenvironments of human tissues better than conventional petri dishes or well-plates. MPS-grown tissue cultures can be used for probing new drugs for their potential primary and secondary toxicities as well as their efficacy. The systems can also be used for assessing the effects of environmental nanoparticles and nanotheranostics, including their rate of uptake, biodistribution, elimination, and toxicity. Pumpless MPS are a group of MPS that often utilize gravity to recirculate cell culture medium through their microfluidic networks, providing some advantages, but also presenting some challenges. They can be operated with near-physiological amounts of blood surrogate (i.e., cell culture medium) that can recirculate in bidirectional or unidirectional flow patterns depending on the device configuration. Here we discuss recent advances in the design and use of both pumped and pumpless MPS with a focus on where pumpless devices can contribute to realizing the potential future role of MPS in evaluating nanomaterials. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials.

Indexed as

Lab-On-A-Chip DevicesMicrophysiological SystemsDrug DiscoveryHumansMicrofluidicsTissue Distributionmicrofluidicsmicrophysiolgical systemsorgans on chips

Identifiers

PMID37464464
PMCPMC11323280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.